2-isopropyl-7-(3-piperidin-1-yl-propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine | 667398-73-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 2-isopropyl-7-(3-piperidin-1-yl-propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine
• 英文别名: 2-isopropyl-7-(3-(piperidin-1-yl)propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine；7-(3-piperidin-1-ylpropoxy)-2-propan-2-yl-1,3,4,5-tetrahydro-2-benzazepine
• CAS: 667398-73-4
• 化学式: C₂₁H₃₄N₂O
• 分子量: 330.514
• InChiKey: YWXFWUFVVULXNJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  15.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-isopropyl-7-(3-piperidin-1-yl-propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine 在 盐酸 作用下， 以 乙醚 、 二氯甲烷 、 水 为溶剂， 生成 2-isopropyl-7-(3-piperidin-1-yl-propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine dihydrochloride
  参考文献：
  名称：

  [EN] SUBSTITUTED AZEPINES AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
  [FR] AZEPINES SUBSTITUEES UTILISEES COMME ANTAGONISTES DES RECEPTEURS H3 DE L'HISTAMINE, LEUR PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES

  摘要：

  本发明公开了新型的Formula (I)的取代氮杂环庚烷化合物或其药学上可接受的盐，其具有选择性组胺-H3受体拮抗活性，以及制备这些化合物的方法。在另一实施方案中，本发明公开了包含这些氮杂环庚烷化合物的药物组合物，以及利用它们治疗肥胖和其他组胺H3受体相关疾病的方法。

  公开号：

  WO2004018432A1
• 作为产物：
  描述：

  2,3,4,5-四氢-1H-苯并[c]氮杂-7-醇 在 盐酸 、 sodium hydroxide 、 MP-CNBH₃ 、 caesium carbonate 、 potassium iodide 作用下， 以 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-isopropyl-7-(3-piperidin-1-yl-propoxy)-2,3,4,5-tetrahydro-1H-benzo[c]azepine
  参考文献：
  名称：

  Synthesis and SAR of novel histamine H3 receptor antagonists

  摘要：

  The synthesis and biological evaluation of novel tetrahydroisoquinoline, tetrahydroquinoline, and tetrahydroazepine antagonists of the human and rat H-3 receptors are described. The substitution around these rings as well as the nature of the substituent on nitrogen is explored. Several compounds with high affinity and selectivity for the human and rat H-3 receptors are reported. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.04.004

文献信息

• Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
  申请人：Gadski Alan Robert

  公开号：US20060089347A1

  公开（公告）日：2006-04-27

  The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.

  本发明披露了一种新型的取代的氮杂七环化合物，其化学式为(I)，或其药学上可接受的盐，具有选择性的组胺H3受体拮抗作用，以及制备这种化合物的方法。在另一种实施方案中，本发明披露了包含这样的氮杂七环化合物的制药组合物，以及使用它们治疗肥胖和其他组胺H3受体相关疾病的方法。
• SUBSTITUTED AZEPINES AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
  申请人：ELI LILLY AND COMPANY

  公开号：EP1539704A1

  公开（公告）日：2005-06-15
• [EN] SUBSTITUTED AZEPINES AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES<br/>[FR] AZEPINES SUBSTITUEES UTILISEES COMME ANTAGONISTES DES RECEPTEURS H3 DE L'HISTAMINE, LEUR PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES
  申请人：LILLY CO ELI

  公开号：WO2004018432A1

  公开（公告）日：2004-03-04

  The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.

  本发明公开了新型的Formula (I)的取代氮杂环庚烷化合物或其药学上可接受的盐，其具有选择性组胺-H3受体拮抗活性，以及制备这些化合物的方法。在另一实施方案中，本发明公开了包含这些氮杂环庚烷化合物的药物组合物，以及利用它们治疗肥胖和其他组胺H3受体相关疾病的方法。
• Synthesis and SAR of novel histamine H3 receptor antagonists
  作者：Cynthia D. Jesudason、Lisa S. Beavers、Jeffrey W. Cramer、Joelle Dill、Don R. Finley、Craig W. Lindsley、F. Craig Stevens、Robert A. Gadski、Samuel W. Oldham、R. Todd Pickard、Christopher S. Siedem、Dana K. Sindelar、Ajay Singh、Brian M. Watson、Philip A. Hipskind

  DOI：10.1016/j.bmcl.2006.04.004

  日期：2006.7

  The synthesis and biological evaluation of novel tetrahydroisoquinoline, tetrahydroquinoline, and tetrahydroazepine antagonists of the human and rat H-3 receptors are described. The substitution around these rings as well as the nature of the substituent on nitrogen is explored. Several compounds with high affinity and selectivity for the human and rat H-3 receptors are reported. (c) 2006 Elsevier Ltd. All rights reserved.